Increased ascites natural killer cells in patients with chronic hepatitis B cirrhosis using lamivudine: A pilot study

Basit Öğe Kaydı
dc.contributor.authorKöker, İbrahim Hakkı
dc.contributor.authorÜnsal, Gülbin
dc.date.accessioned2024-06-12T10:13:20Z
dc.date.available2024-06-12T10:13:20Z
dc.date.issued2019
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBackground and Aims: Natural killer cells play a direct role in liver injury and fibrogenic response. Peripheral blood natural killer cells have been studied widely in chronic liver diseases. We aimed to evaluate the ascites natural killer cell frequency and its significance in chronic hepa-titis B related cirrhosis. Materials and Methods: Overall, 30 patients (23 males) with decompensated chronic hepatitis B cirrhosis with ascites were included. Patients with a recent ascites infection history and other etiologic factors besides chronic hepatitis B infection were excluded. Af-ter defining the demographic characteristics of the cases, we divided patients according to their Child-Turcotte-Pugh classification scores into two groups, and their natural killer (CD3?/CD16+/CD56+) cell frequen-cies in peripheral blood and ascites were studied using flow cytometry. Finally, we compared the natural killer cell frequencies in peripheral blo-od and ascites between the Child-Turcotte-Pugh classification groups ba-sed on lamivudine use. Results: Median lamivudine usage duration was 60 months, interquartile range 18.7–93 months in Child-Turcotte-Pugh B and 7.5 months, interquartile range 2.2–21 months in Child-Turcot-te-Pugh C (p = 0.053). Ascites natural killer cells were significantly incre-ased in lamivudine users of Child-Turcotte-Pugh B (p = 0.049), whereas no change was observed in peripheral blood - natural killer frequency in patients using lamivudine in the Child-Turcotte-Pugh B and C groups (p=0.574 and p = 0.174, respectively). Conclusion: Long-term lamivudine use might have increased the ascites natural killer frequency, whereas no change was observed in the peripheral blood - natural killer cell frequ-ency in patients with chronic hepatitis B cirrhosis, suggesting a potential role of antivirals in ascites natural killer cell response.en_US
dc.identifier.endpage86en_US
dc.identifier.issn1303-6629
dc.identifier.issn2149-0600
dc.identifier.issue3en_US
dc.identifier.startpage80en_US
dc.identifier.trdizinid328397en_US]
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/328397
dc.identifier.urihttps://hdl.handle.net/20.500.14551/13923
dc.identifier.volume18en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAkademik Gastroenteroloji Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleIncreased ascites natural killer cells in patients with chronic hepatitis B cirrhosis using lamivudine: A pilot studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu